Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHOP versus PMitCEBO with or without G-CSF in older adults with aggressive non-Hodgkin's lymphoma
ISRCTN98741793Phase 3Completed
- Sponsor
- Lymphoma Research Trust
- Start
- Dec 1996
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, open-label trial of cyclophosphamide, doxorubicin, vincristine, prednisolone, mitoxantrone and 3 more in non-Hodgkin lymphoma (NHL) (4 arms), sponsored by Lymphoma Research Trust. Primary endpoint: Failure-free survival. Started Dec 1996; status: completed.
02
Drugs
cyclophosphamidedoxorubicinvincristineprednisolonemitoxantrone
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on ISRCTN98741793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN98741793.